Fundraising FoxCowen Healthcare Investments — 2020 Investments
1 investments dated 2020 · listed companies and verified rows first · show all
Escient Pharmaceuticalsescientpharma.comAug 2020SEC filingmedium confidence
Company developing molecules targeting a novel class of receptors for neuro-immuno-inflammatory diseases; acquired by Incyte in May 2024.
BiotechSan Diego, US
Alain Baron(Founder)JeenJoo Kang(Director)Robert Tjian(Director)Marcus Boehm(Founder)
BoardAndrew Schwab(Director)in
Board seatKevin Raidy· per SEC Form D · $120M raise · filed Nov 2022
Co-investors5AM VenturesAvego BioScience CapitalNew Enterprise Associates (NEA)OUP (Osage University Partners)Sanofi VenturesThe Column Group+2 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.